FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: referentieset voor associaties betreffende vervangende concepten (metadata)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
9093651000146111 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
9093661000146114 referentieset voor associaties betreffende vervangende concepten (metadata) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


20431 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Donepezil 1mg/mL oral solution Donepezil hydrochloride 1 mg/mL oral solution
Donepezil 5mg orally disintegrating tablet Donepezil hydrochloride 5 mg orodispersible tablet
Dopamine hydrochloride 160mg/mL infusion concentrate 5mL ampule Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dopamine hydrochloride 40mg/mL infusion concentrate 5mL ampule Dopamine hydrochloride 40 mg/mL solution for injection
Dopexamine hydrochloride 10mg/mL infusion concentrate 5mL ampule Product containing precisely dopexamine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Dornase alfa 2500units(2.5mg) nebulizer solution Dornase alfa 1 mg/mL solution for nebuliser
Dorsal finger flap Flap (substance)
Dorsal metatarsal fasciocutaneous flap Dorsal metatarsal artery fasciocutaneous flap
Dorsal thumb flap Flap (substance)
Dorsal tongue flap Flap (substance)
Dorsalis pedis flap Dorsalis pedis artery flap
Dorsolateral sulcus Medulla oblongata dorsal lateral sulcus
Dose form by site prepared for Pharmaceutical dose form (dose form)
Dothiepin hydrochloride 25mg/5mL conventional release oral elixir Dosulepin 5 mg/mL oral solution
Dothiepin hydrochloride 25mg/5mL s/f elixir Dosulepin 5 mg/mL oral solution
Dothiepin hydrochloride 75mg/5mL conventional release oral elixir Dosulepin 15 mg/mL oral solution
Dothiepin hydrochloride 75mg/5mL s/f elixir Dosulepin 15 mg/mL oral solution
Double - DT - vaccination Preschool administration of diphtheria and tetanus vaccine
Double - DT - vaccination (& [pre-school] ) Preschool administration of diphtheria and tetanus vaccine
Down's incontinence apparatus Incontinence appliance (physical object)
Down's screening blood test NOS Down's screening status
Down's screening blood test NOS Down's screening - blood test
Down's syndrome NOS Complete trisomy 21 syndrome
Down's syndrome NOS Complete trisomy 21 syndrome
Doxazosin mesylate 8mg tablet Doxazosin (as doxazosin mesilate) 8 mg oral tablet
Doxepin hydrochloride 10mg/mL oral solution Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug)
Doxepin metabolite Product containing doxepin (medicinal product)
Doxorubicin hydrochloride 10mg injection solution vial Doxorubicin hydrochloride 10 mg powder for solution for injection vial
Doxorubicin hydrochloride 20mg injection solution vial Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug)
Doxorubicin liposomal 20mg/10ml injection Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug)
Doxycycline 100mg dispersible tablet Doxycycline 100 mg orodispersible tablet
Doxycycline 40mg m/r capsule Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug)
Doxycycline 75mg orally disintegrating tablet Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet
Doxycycline calcium 50mg/5mL syrup Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)
Doxycycline hyclate 10% subgingival delivery system Product containing only doxycycline in oromucosal dose form (medicinal product form)
Doxycycline hyclate 200mg injection (pdr for recon) Product containing only doxycycline in parenteral dose form (medicinal product form)
Doxycycline hyclate 200mg powder for injection solution vial Product containing only doxycycline in parenteral dose form (medicinal product form)
Doxycycline monohydrate 25mg/5mL suspension Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension
Drain insertion - action Insertion - action (qualifier value)
Drainage of boil of skin NEC Drainage of boil of skin
Drainage of cyst NEC Drainage procedure
Drainage of cyst of pancreas into jejunum NEC Pancreaticocystojejunostomy
Drainage of organ NOC Drainage procedure
Drainage of organ NOC NOS Drainage procedure
Drechslera longirostrata Exserohilum longirostratum
Dressing - action Application - action
Dried factor IX fraction heated 600iu powder and solvent for injection solution vial Product containing only coagulation factor IX in parenteral dose form (medicinal product form)
Dried factor IX fraction heated 600iu powder for conventional release solution for injection solution vial Product containing only coagulation factor IX in parenteral dose form (medicinal product form)
Drilling of organ NOC Drilling
Drimaren heldergeel K-3GL Textile colours and finishes patch test substance
Drostanolone propionate allergy Allergy to drostanolone (finding)
Drotrecogin alfa (activated) 5mg powder for infusion solution vial Drotrecogin alfa 5 mg powder for solution for injection vial
Drotrecogin alfa 20mg powder for infusion solution vial Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Drug Pharmaceutical / biologic product (product)
Drug addiction notif NOS Drug addiction notification status
Drug addiction notif NOS Drug addiction notification
Drug aerosol, 0,01% Drug aerosol
Drug aerosol, 0,04% Drug aerosol
Drug aerosol, 0,5% Drug aerosol
Drug cream, 0,01% Cream
Drug cream, 0,02% Cream
Drug cream, 0,025% Cream
Drug cream, 0,05% Cream
Drug cream, 0,1% Cream
Drug cream, 0,25% Cream
Drug cream, 0,5% Cream
Drug cream, 1% Cream
Drug cream, 2,5% Cream
Drug dependence - unspecified whether during pregnancy or the puerperium Substance dependence during pregnancy, childbirth and/or puerperium (disorder)
Drug dependence NOS Substance dependence (disorder)
Drug dependence NOS Substance dependence (disorder)
Drug dependence during childbirth, puerperium (& pregnancy) Substance dependence during pregnancy, childbirth and/or puerperium (disorder)
Drug dependence during pregnancy, childbirth or the puerperium NOS Substance dependence during pregnancy, childbirth and/or puerperium (disorder)
Drug for supraventricular arrhythmia Antiarrhythmic agent (substance)
Drug for ventricular arrhythmia Antiarrhythmic agent (substance)
Drug gel, 0,05% Gel
Drug gel, 0,1% Gel
Drug gel, 0,25% Gel
Drug groups and agents primarily acting on skin adverse reaction Adverse reaction to drug
Drug groups primarily affecting autonomic nervous system adverse reaction Adverse reaction to drug
Drug groups primarily affecting central nervous system adverse reaction Adverse reaction to drug
Drug groups primarily affecting gastrointestinal system adverse reaction Adverse reaction to drug
Drug groups primarily affecting musculoskeletal system adverse reaction Adverse reaction to drug
Drug groups primarily affecting respiratory system adverse reaction Adverse reaction to drug
Drug groups primarily affecting the autonomic nervous system Product containing autonomic agent (product)
Drug hypersensitivity Propensity to adverse reactions to drug
Drug hypersensitivity (& [NOS]) Propensity to adverse reactions to drug
Drug hypersensitivity NOS Propensity to adverse reactions to drug
Drug induced rash (& ingestion dermatitis) Dermatitis caused by substance taken via oral route (disorder)
Drug ointment, 0,025% Ointment
Drug ointment, 0,05% Ointment
Drug ointment, 0,1% Ointment
Drug ointment, 0,2% Ointment
Drug ointment, 0,25% Ointment
Drug ointment, 1% Ointment
Drug ointment, 2,5% Ointment
Drug reaction - CNS drug Adverse reaction to drug
Drug reaction - CNS drug Adverse reaction to drug
Drug reaction - CNS drug NOS Adverse reaction to drug
Drug reaction - CNS drug NOS Adverse reaction to drug
Drug reaction to analgesic NOS Analgesic adverse reaction

Start Previous Page 40 of 205 Next End


Reference Sets

Reference set descriptor

Back to Start